A Pathway Through the Bundle Jungle
- 1 June 2016
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 12 (6), 504-509
- https://doi.org/10.1200/jop.2015.008789
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer DrugsMayo Clinic Proceedings, 2015
- Pricing in the Market for Anticancer DrugsJournal of Economic Perspectives, 2015
- Payment for Oncolytics in the United States: A History of Buy and Bill and Proposals for ReformJournal of Oncology Practice, 2014
- Acute Hospital Care Is The Chief Driver Of Regional Spending Variation In Medicare Patients With Advanced CancerHealth Affairs, 2014
- The Impact of Emerging Safety and Effectiveness Evidence on the Use of Physician-administered DrugsMedical Care, 2013
- Toward Accountable Cancer CareJAMA Internal Medicine, 2013
- The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML expertsPublished by American Society of Hematology ,2013
- Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical OncologistsJournal of Clinical Oncology, 2013
- The High Cost of Cancer Drugs and What We Can Do About ItMayo Clinic Proceedings, 2012
- Episode-Based Payment For Cancer Care: A Proposed Pilot For MedicareHealth Affairs, 2011